{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:09:47Z","timestamp":1789546187117,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,7,1]]},"DOI":"10.1093\/ndt\/16.7.1368","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:55:00Z","timestamp":1027724100000},"page":"1368-1373","source":"Crossref","is-referenced-by-count":44,"title":["Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection"],"prefix":"10.1093","volume":"16","author":[{"given":"Satu","family":"M\u00e4kel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hurme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilpo","family":"Ala\u2010Houhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna\u2010Maija","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Partanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Vaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,7]]},"reference":[{"key":"key\n\t\t\t\t20180110081248_R1","doi-asserted-by":"crossref","unstructured":"Kanerva M, Mustonen J, Vaheri A. Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol1998; 8: 67\u201386","DOI":"10.1002\/(SICI)1099-1654(199804\/06)8:2<67::AID-RMV217>3.0.CO;2-U"},{"key":"key\n\t\t\t\t20180110081248_R2","doi-asserted-by":"crossref","unstructured":"Brummer\u2010Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A. Epidemiological study of nephropathia epidemica in Finland 1989\u201396. Scand J Infect Dis1999; 31: 427\u2013435","DOI":"10.1080\/00365549950163941"},{"key":"key\n\t\t\t\t20180110081248_R3","doi-asserted-by":"crossref","unstructured":"Mustonen J, Brummer\u2010Korvenkontio M, Hedman K, Pasternack A, Pietil\u00e4 K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis1994; 26: 7\u201313","DOI":"10.3109\/00365549409008583"},{"key":"key\n\t\t\t\t20180110081248_R4","doi-asserted-by":"crossref","unstructured":"Mustonen J, Partanen J, Kanerva M et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int1996; 49: 217\u2013221","DOI":"10.1038\/ki.1996.29"},{"key":"key\n\t\t\t\t20180110081248_R5","doi-asserted-by":"crossref","unstructured":"Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med1994; 45: 491\u2013503","DOI":"10.1146\/annurev.med.45.1.491"},{"key":"key\n\t\t\t\t20180110081248_R6","doi-asserted-by":"crossref","unstructured":"Linderholm M, Ahlm C, Settergren B, Waage A, T\u00e4rnvik A. Elevated plasma levels of tumor necrosis factor (TNF)\u2010alpha, soluble TNF receptors, interleukin (IL)\u20106 and IL\u201010 in patients with hemorrhagic fever with renal syndrome. J Infect Dis1996; 173: 38\u201343","DOI":"10.1093\/infdis\/173.1.38"},{"key":"key\n\t\t\t\t20180110081248_R7","doi-asserted-by":"crossref","unstructured":"Hajeer AH, Hutchinson IV. TNF\u2010alpha gene polymorphism: clinical and biological implications. Microsc Res Tech2000; 50: 216\u2013228","DOI":"10.1002\/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20180110081248_R8","doi-asserted-by":"crossref","unstructured":"Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet1992; 1: 353","DOI":"10.1093\/hmg\/1.5.353"},{"key":"key\n\t\t\t\t20180110081248_R9","doi-asserted-by":"crossref","unstructured":"Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA1997; 94: 3195\u20133199","DOI":"10.1073\/pnas.94.7.3195"},{"key":"key\n\t\t\t\t20180110081248_R10","doi-asserted-by":"crossref","unstructured":"Kanerva M, Vaheri A, Mustonen J, Partanen J. High\u2010producer allele of tumour necrosis factor\u2010alpha is part of the susceptibility MHC haplotype in severe Puumala virus\u2010induced nephropathia epidemica. Scand J Infect Dis1998; 30: 532\u2013534","DOI":"10.1080\/00365549850161629"},{"key":"key\n\t\t\t\t20180110081248_R11","doi-asserted-by":"crossref","unstructured":"di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at \u2212511 in the human interleukin\u20101 beta gene (IL1 beta). Hum Mol Genet1992; 1: 450","DOI":"10.1093\/hmg\/1.6.450"},{"key":"key\n\t\t\t\t20180110081248_R12","doi-asserted-by":"crossref","unstructured":"Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin\u20101 beta (IL\u20101 beta) gene correlates with IL\u20101 beta secretion in vitro. Eur J Clin Invest1992; 22: 396\u2013402","DOI":"10.1111\/j.1365-2362.1992.tb01480.x"},{"key":"key\n\t\t\t\t20180110081248_R13","doi-asserted-by":"crossref","unstructured":"McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin\u20101 alpha polymorphism. Arthritis Rheum1995; 38: 221\u2013228","DOI":"10.1002\/art.1780380210"},{"key":"key\n\t\t\t\t20180110081248_R14","doi-asserted-by":"crossref","unstructured":"Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL\u20101 receptor antagonist gene intron 2 is caused by variable numbers of an 86\u2010bp tandem repeat. Hum Genet1993; 91: 403\u2013404","DOI":"10.1007\/BF00217368"},{"key":"key\n\t\t\t\t20180110081248_R15","doi-asserted-by":"crossref","unstructured":"Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med1998; 30: 469\u2013473","DOI":"10.3109\/07853899809002488"},{"key":"key\n\t\t\t\t20180110081248_R16","doi-asserted-by":"crossref","unstructured":"Hurme M, Santtila S. IL\u20101 receptor antagonist (IL\u20101Ra) plasma levels are co\u2010ordinately regulated by both IL\u20101Ra and IL\u20101beta genes. Eur J Immunol1998; 28: 2598\u20132602","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K"},{"key":"key\n\t\t\t\t20180110081248_R17","doi-asserted-by":"crossref","unstructured":"Miller SC, Ito H, Blau HM, Torti FM. Tumor necrosis factor inhibits human myogenesis in vitro. Mol Cell Biol1988; 8: 2295\u20132301","DOI":"10.1128\/MCB.8.6.2295"},{"key":"key\n\t\t\t\t20180110081248_R18","doi-asserted-by":"crossref","unstructured":"Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin\u20101 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet1998; 62: 1180\u20131188","DOI":"10.1086\/301817"},{"key":"key\n\t\t\t\t20180110081248_R19","doi-asserted-by":"crossref","unstructured":"Hurme M, Helminen M. Polymorphism of the IL\u20101 gene complex in Epstein\u2010Barr virus seronegative and seropositive adult blood donors. Scand J Immunol1998; 48: 219\u2013222","DOI":"10.1046\/j.1365-3083.1998.00406.x"},{"key":"key\n\t\t\t\t20180110081248_R20","doi-asserted-by":"crossref","unstructured":"Mira JP, Cariou A, Grall F et al. Association of TNF2, a TNF\u2010alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. J Am Med Assoc1999; 282: 561\u2013583","DOI":"10.1001\/jama.282.6.561"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/16\/7\/1368\/23370538\/161368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:30:04Z","timestamp":1583314204000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/16\/7\/1368\/1815215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,1]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2001,7]]},"published-print":{"date-parts":[[2001,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/16.7.1368","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,7]]},"published":{"date-parts":[[2001,7,1]]}}}